跳至主要内容
临床试验/DRKS00025863
DRKS00025863已完成未知

Evaluation of SARS-CoV-2-specific Serumparameters in Blood Samples of SARS-CoV-2-seronegative Volunteers as well as former Patients with Healed, Asymptomatic, Mild or Severe COVID-19-Courses (HTXCOV-01B) - COVIAS_B

Heidelberg ImmunoTherapeutics GmbH0 个研究点目标入组 35 人开始时间: 2021年7月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. the subject/former COVID-19 patient has given consent to participate in the study.
  • 2. The subject/former COVID-19 patient is at least 18 years old and able to give consent.
  • 3. evidence of at least a single positive SARS-CoV-2 smear PCR test (groups b-d) or antibody test for COVID-19.
  • 4. sufficient information for group assignment as well as on the course of COVID-19 disease.

排除标准

  • 1. participants who have already been vaccinated against SARS-CoV-2 cannot participate.
  • 2. any illness or condition which, in the opinion of the physician providing the information, does not medically allow the blood sample to be taken.

研究者

相似试验